ELTP vs Peers Stock Comparison

Elite Pharmaceuticals Prices as of Oct 26, 2026 Peers: Industry group

Percentile Scorecard

ELTP

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisELTP
Valuation 96 #11 of 275
Growth 93 #20 of 253
Profitability 93 #16 of 224
Financial Health 76 #73 of 296
Shareholder Returns 83 #22 of 126
Overall 88
  • ELTP ranked among 305 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodELTPSPY
1 month -7.7% -0.8%
3 months -36.8% +3.5%
6 months -31.4% +7.0%
Year to date -51.0% +12.2%
1 year -61.9% +13.0%
3 years +100.0% +86.3%
3 years, per year +26.0% +23.1%
5 years +500.0% +68.6%
5 years, per year +43.1% +11.0%
10 years +50.0% +258.0%
10 years, per year +4.1% +13.6%

Risk

MeasureELTPSPY
Volatility, 1Y 57.5% 12.7%
Downside volatility, 1Y 71.6% 12.7%
Beta vs S&P 500, 1Y 0.69 1.00
Return / volatility, 1Y -1.08 1.02
Max drawdown, 5Y -71.4% -25.4%
From 52-week high -64.7% -1.8%
52-week high $0.68 $779.14
52-week low $0.22 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleELTP
P/E now vs peer median 4.6xmedian 10.4x
P/S now vs peer median 1.8xmedian 6.4x
EV/EBITDA now vs peer median 6.1xmedian 10.7x
P/FCF now vs peer median 14.8xmedian 12.5x
P/B now vs peer median 2.5xmedian 1.6x
PEG now vs peer median 0.04median 0.29

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsELTP
Revenue $141.01M
Gross profit $61.31M
Operating income $34.94M
Net income $56.67M
Free cash flow $17.53M
R&D $6.10M
EPS (diluted) $0.05
Cash & equivalents $39.42M
Total debt $9.58M
Shares (diluted) 1.13B
Enterprise value $140.18M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricELTP
P/E 4.6x
P/FCF 14.8x
P/Operating cash flow 13.6x
P/S 1.8x
P/B 2.5x
P/Tangible book 2.6x
EV/EBITDA 6.1x
EV/EBIT 6.3x
EV/Revenue 1.6x
EV/FCF 12.6x
EV/Operating cash flow 11.6x
PEG (3Y EPS CAGR) 0.04

Growth

14 metrics
MetricELTP
Revenue growth (1Y) 33.7%
Revenue CAGR (3Y) 58.4%
Gross profit growth (1Y) 4.2%
Gross profit CAGR (3Y) 53.5%
Operating income growth (1Y) -6.7%
Operating income CAGR (3Y) 101.7%
Net income growth (1Y) 624.0%
Net income CAGR (3Y) 134.4%
EPS growth (1Y) 596.0%
EPS CAGR (3Y) 118.3%
Operating cash flow growth (1Y) -0.2%
Operating cash flow CAGR (3Y) 152.2%
Free cash flow growth (1Y) -2.8%
Free cash flow CAGR (3Y) 81.0%

Profitability

14 metrics
MetricELTP
Gross margin 43.5%
EBITDA margin 25.9%
Operating margin 24.8%
Pretax margin 46.2%
Net margin 40.2%
FCF margin 12.4%
Operating cash flow margin 13.5%
Return on equity 55.6%
Return on assets 40.8%
Return on invested capital 29.2%
Return on capital employed 32.2%
Asset turnover 1.0x
Cash conversion (OCF / net income) 0.3x
Stock comp / revenue 0.1%

Financial Health

11 metrics
MetricELTP
Debt / assets 1.7%
Debt / equity 0.0x
Net debt / EBITDA -1.0x
Debt / FCF 0.1x
Liabilities / assets 24.9%
Equity / assets 75.1%
Interest coverage 69.4x
Current ratio 3.8x
Quick ratio 3.0x
Cash ratio 1.3x
Altman Z-score 6.31

Shareholder Returns

7 metrics
MetricELTP
Dividend yield –
Net buyback yield -0.1%
Shareholder yield -0.1%
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusELTP

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersELTP
Held by institutions 0.0%
Institutions holding 1
Change in shares held, QoQ –
Institutions buying 1
Institutions selling 0
Buyers to sellers –

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.